MedTrace Logo

Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study

NCT05950750 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 960

Last updated 2023-07-18

No results posted yet for this study

Summary

21 hematology centers in Turkey will participate in this noninterventional observational study. The recruitment target is 960 cases. Patients will be followed-up at least 1 year or to the end of the study according to the physicians' discretion, or withdrawal of consent. Recruitment period will be 36 months. Data will be collected via electronic case report form. Since the study cohort does not include only newly diagnosed patients, all aTTP patients will be included to the study, previous treatments and diagnosis information data could also be collected from hospital records. Patients recruitment duration: 3 years (36 months) Patients follow-up duration: 1 year (12 months)

Conditions

  • TTP - Thrombotic Thrombocytopenic Purpura

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Turkish Hematology Association

    lead OTHER

Principal Investigators

  • ilker kurkcu · Sentez-CRO

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-21
Primary Completion
2023-12-21
Completion
2026-12-21

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05950750 on ClinicalTrials.gov